Chih-Cheng Lai to Piperidines
This is a "connection" page, showing publications Chih-Cheng Lai has written about Piperidines.
Connection Strength
0.142
-
Clinical efficacy and safety of Janus kinase inhibitors for COVID-19: A systematic review and meta-analysis of randomized controlled trials. Int Immunopharmacol. 2021 Oct; 99:108027.
Score: 0.142